Immune Pharmaceuticals Granted Additional Time to Comply with...

2017-03-13T10:57:56-07:00

NEW YORK, March 13, 2017 /PRNewswire/ — Immune Pharmaceuticals Inc. (Nasdaq: IMNP) (“Immune” or the “Company”), announced today that following a hearing on March 9, 2017, where the Company presented ...